Bioxytran's total assets for Q3 2025 were $156.29K, an increase of 5.96% from the previous quarter. BIXT total liabilities were $3.06M for the fiscal quarter, a 10.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.